HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of bronchiolitis obliterans syndrome successfully treated by Tiotropium bromide].

Abstract
A 48-year-old woman was admitted with dyspnea on effort. She suffered from adult T-cell leukemia and received peripheral blood stem cell transplantation (PBSCT). Eight months after the PBSCT, she developed dyspnea on effort and was treated with bronchodilator, inhaled corticosteroid, anti-leukotriene drug, theophylline and oxytropium bromide. However her symptoms progressed and she was admitted. We diagnosed bronchiolitis obliterans syndrome (BOS) because of obstructive pulmonary dysfunction, diffuse patchy high density of the lung field on chest computed tomography and decreased ventilation with peripheral patchy accumulation on ventilation scintigraphy. She was treated with corticosteroid and cyclosporine A and her symptoms and her pulmonary function were improved. However, in parallel with corticosteroid tapering, her symptoms and pulmonary functions worsened. Treatment with Tiotropium bromide was started and her pulmonary function improved significantly. Her pulmonary function did not worsen and tapering steroid dose was successfully achieved. PBSCT was reported to up-regulate the muscarinic receptor activity in lung. Tiotropium bromide might become one additional option for the treatment of BOS.
AuthorsWataru Matsuyama, Masuki Yamamoto, Kentarou Machida, Ken-Ichi Oonakahara, Masaki Watanabe, Ikkou Higashimoto, Mitsuhiro Osame, Kimiyoshi Arimura
JournalNihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society (Nihon Kokyuki Gakkai Zasshi) Vol. 44 Issue 5 Pg. 404-9 (May 2006) ISSN: 1343-3490 [Print] Japan
PMID16780100 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Bronchodilator Agents
  • Scopolamine Derivatives
  • Tiotropium Bromide
Topics
  • Bronchiolitis Obliterans (drug therapy, etiology)
  • Bronchodilator Agents (therapeutic use)
  • Drug Administration Schedule
  • Female
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell (complications, therapy)
  • Middle Aged
  • Remission Induction
  • Scopolamine Derivatives (therapeutic use)
  • Tiotropium Bromide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: